Drug cell line interaction prediction
Understanding the phenotypic drug response on cancer cell lines plays a vital rule in anti-cancer drug discovery and re-purposing. The Genomics of Drug Sensitivity in Cancer (GDSC) database provides open data for researchers in phenotypic screening to test their models and methods. Previously, most research in these areas starts from the fingerprints or features of drugs, instead of their structures. In this paper, we introduce a model for phenotypic screening, which is called twin Convolutional Neural Network for drugs in SMILES format (tCNNS). tCNNS is comprised of CNN input channels for drugs in SMILES format and cancer cell lines respectively. Our model achieves $0.84$ for the coefficient of determinant($R^2$) and $0.92$ for Pearson correlation($R_p$), which are significantly better than previous works\cite{ammad2014integrative,haider2015copula,menden2013machine}. Besides these statistical metrics, tCNNS also provides some insights into phenotypic screening.
Code (1)
Tasks
Drug DiscoveryPredictionSimilar Papers 제목 키워드 기반
MOTIVE: A Drug-Target Interaction Graph For Inductive Link Prediction
Drug-target interaction (DTI) prediction is crucial for identifying new therapeutics and detecting mechanisms of action. While structure-based methods accurately model physical interactions between a drug and its protein…
Drug DiscoveryInductive Link PredictionLink PredictionPrecision Anti-Cancer Drug Selection via Neural Ranking
Personalized cancer treatment requires a thorough understanding of complex interactions between drugs and cancer cell lines in varying genetic and molecular contexts. To address this, high-throughput screening has been u…
Drug Response PredictionDDoS: A Graph Neural Network based Drug Synergy Prediction Algorithm
Drug synergy arises when the combined impact of two drugs exceeds the sum of their individual effects. While single-drug effects on cell lines are well-documented, the scarcity of data on drug synergy, considering the va…
Graph Neural NetworkTowards Explainable Anticancer Compound Sensitivity Prediction via Multimodal Attention-based Convolutional Encoders
In line with recent advances in neural drug design and sensitivity prediction, we propose a novel architecture for interpretable prediction of anticancer compound sensitivity using a multimodal attention-based convolutio…
Drug DesignPredictionSensitivityMOOMIN: Deep Molecular Omics Network for Anti-Cancer Drug Combination Therapy
We propose the molecular omics network (MOOMIN) a multimodal graph neural network used by AstraZeneca oncologists to predict the synergy of drug combinations for cancer treatment. Our model learns drug representations at…
Graph Neural Network